Pura Vida Investments’s NEVRO CORP. NVRO Stock Holding History

Pura Vida Investments’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80,000	Closed	-$9.31M	–	318
2021 Q3	$9.31M	Buy	+80,000	New	+$10.5M	0.28%	91
2021 Q1	–	Sell	-15,000	Closed	-$2.6M	–	265
2020 Q4	$2.6M	Buy	+15,000	New	+$2.43M	0.09%	133
2020 Q1	–	Sell	-92,000	Closed	-$10.8M	–	131
2019 Q4	$10.8M	Buy	+92,000	New	+$9.11M	0.95%	38

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pura Vida Investments's NVRO Position: Q4 2021 in Review

Pura Vida Investments sold out of NEVRO CORP. (NVRO) in Q4 2021, closing a stake of 10,000 shares — an estimated $1.16M sold.

Pura Vida Investments first reported a position in NVRO in Q4 2014 and held it in 5 quarters. The position peaked at $4.97M in Q2 2021. 209 funds tracked by Wall St. Rank hold NVRO as of Q4 2021.

Pura Vida Investments reported no remaining NEVRO CORP. position as of Q4 2021 after selling out during the quarter.
Pura Vida Investments sold 10,000 NEVRO CORP. shares in Q4 2021, an estimated $1.16M.
Pura Vida Investments first reported a position in NEVRO CORP. in Q4 2014 and held it in 5 quarters.
Pura Vida Investments's NEVRO CORP. position peaked at $4.97M in Q2 2021.
209 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.